Dr. Paul Bollyky was chosen as a 2017 Harrington awardee.
The Scholar-Innovator award will fund development of our Type 1 diabetes drug. The Harrington award looks for research with potential for breakthrough discoveries with impacts in clinical treatment.
Check out the other Harrington awardees here.
